信息
GEXVal's Drug Repurposing Study Using GATE-Based AI Technology Published in Journal “Pharmaceuticals”New!!
2026年9月25日
株式会社GEXVal September 25, 2026 GEXVal Publishes COVID-19 Drug Repurposing Study Using Its AI Technology GATE in […]
GEXVal to present AI Drug Discovery Platform RePhaIND® at BioJapan SeminarNew!!
2026年9月25日
株式会社GEXVal September 25, 2026 GEXVal Inc. to Present at BioJapan 2026 Seminar “From Analytical AI to Explorato […]
GEXVal to Exhibit at BioJapan 2026New!!
2026年9月25日
株式会社GEXVal September 25, 2026 GEXVal to Showcase AI-Powered Drug Discovery Platform RePhaIND® at BioJapan 2026 […]
GEXVal CEO Invited to Speak at "Australia-Japan Innovation Alliance Forum 2026"
2026年9月18日
株式会社GEXVal September 18, 2026 GEXVal CEO Invited to Speak at "Australia-Japan Innovation Alliance Forum 2026" […]
GEXVal CEO Invited to Speak at "YOKOHAMA DEEP TECH GLOBAL BRIDGE 2026"
2026年9月15日
株式会社GEXVal September 15, 2026 GEXVal CEO Invited to Speak at "YOKOHAMA DEEP TECH GLOBAL BRIDGE 2026" GE […]


